The global scientific and medical community is on the cusp of witnessing a major shift in the landscape of diagnostic imaging, as pharmaceutical titan Bayer seeks approval from the U.S. Food and Drug Administration (FDA) for its breakthrough contrast agent, Gadoquatrane. This revolutionary agent is designed for use in magnetic resonance imaging (MRI) of the […]